Ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) reported Q3 CY2025 results , but sales fell by 5.7% ...

Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the low priced stocks to buy with high upside potential. On December 12, Bank of America raised the firm’s price target on Ocular Therapeutix to $21 ...

For most of last year, Ocular Therapeutix CEO Antony Mattessich promised shareholders that he was close to nailing down a lucrative pharma partnership that would pay for late-stage clinical trials of ...

Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable ...

I found this issue’s cover story on the role of the microbiome in eye health and disease quite interesting. A normal ...

Refractory dry eye in patients with systemic comorbidities can be challenging to manage because the underlying condition or ...

The Pooled Cohort Equations (PCE) cardiovascular risk score stratifies risk for multiple ocular diseases, according to a ...

Ocular albinism is a genetic condition that involves the eyes. This condition reduces the pigmentation of the iris — the colored part of the eye — and the retina, causing vision problems. Albinism is ...

An ocular migraine (also called a retinal migraine) is a rare type of migraine headache that causes visual symptoms in one of your eyes. The problem isn't with your eyes; it's a problem with the way ...

Ocular migraine is associated with visual disturbances and may be related to genetics, as research suggests a significant genetic component in migraine. Hormonal fluctuations, particularly drops in ...

There is currently no cure for ocular albinism. However, people can manage their condition with low vision aids and protective eyewear. In some cases, doctors may perform eye surgery. Albinism is an ...